Literature DB >> 17548597

Disregulated influenza A virus-specific CD8+ T cell homeostasis in the absence of IFN-gamma signaling.

Stephen J Turner1, Elvia Olivas, Astrid Gutierrez, Gabriela Diaz, Peter C Doherty.   

Abstract

Recent studies indicate that IFN-gamma may influence both the expansion and the trafficking of virus-specific CD8+ CTL, though the effects are not necessarily consistent for different models of viral and bacterial disease. Influenza A virus infection of mice deficient for IFN-gamma (IFN-gamma(-/-)) or deficient for the IFN-gamma receptor 1 (IFNGR1(-/-)) was, when compared with the wild-type (WT) B6 controls, associated with increased Ag-specific CD8+ T cell counts in the spleen and mediastinal lymph nodes. At the same time, fewer of these CTL effectors were found in the bronchoalveolar lavage population recovered from the IFN-gamma(-/-) mice. Comparable effects were observed for WT mice treated with a neutralizing IFN-gamma-specific mAb. Transfer of WT memory Thy1.1(+) CD8+ populations into Thy1.2+ B6 IFN-gamma(-/-) or IFNGR1(-/-) mice followed by intranasal virus challenge demonstrated both that IFN-gamma produced by the host was important for the regulation of Ag-specific CTL numbers and that IFN-gamma was likely to act directly on the T cells themselves. In addition, the prevalence of CTLs undergoing apoptosis in spleen was lower when measured directly ex vivo for IFN-gamma(-/-) vs WT B6 mice. The present analysis is the first comprehensive demonstration that IFN-gamma signaling can differentially regulate both Ag-specific CTL homeostasis in secondary lymphoid organs and trafficking to a site of virus-induced pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548597     DOI: 10.4049/jimmunol.178.12.7616

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Gamma interferon regulates contraction of the influenza virus-specific CD8 T cell response and limits the size of the memory population.

Authors:  Nayana Prabhu; Adrian W Ho; Kenneth H S Wong; Paul Edward Hutchinson; Yen Leong Chua; Matheswaran Kandasamy; Debbie C P Lee; Baalasubramanian Sivasankar; David Michael Kemeny
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.

Authors:  Joselyn Rojas-Quintero; Xiaoyun Wang; Jennifer Tipper; Patrick R Burkett; Joaquin Zuñiga; Amit R Ashtekar; Francesca Polverino; Amit Rout; Ilyas Yambayev; Carmen Hernández; Luis Jimenez; Gustavo Ramírez; Kevin S Harrod; Caroline A Owen
Journal:  JCI Insight       Date:  2018-12-20

Review 3.  Innate immune evasion strategies of influenza viruses.

Authors:  Benjamin G Hale; Randy A Albrecht; Adolfo García-Sastre
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

4.  IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration.

Authors:  Lidia Yshii; Béatrice Pignolet; Emilie Mauré; Mandy Pierau; Monika Brunner-Weinzierl; Oliver Hartley; Jan Bauer; Roland Liblau
Journal:  JCI Insight       Date:  2019-04-04

5.  Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.

Authors:  John R Teijaro; David Verhoeven; Carly A Page; Damian Turner; Donna L Farber
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 6.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

7.  Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells.

Authors:  Simon H Apte; Adriana Baz; Penny Groves; Anne Kelso; Norbert Kienzle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

Review 8.  The effector T cell response to influenza infection.

Authors:  Matthew M Hufford; Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 9.  Translating costimulation blockade to the clinic: lessons learned from three pathways.

Authors:  Mandy L Ford; Christian P Larsen
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.

Authors:  G Ahlén; E Derk; M Weiland; J Jiao; N Rahbin; S Aleman; D L Peterson; K Pokrovskaja; D Grandér; L Frelin; M Sällberg
Journal:  Gut       Date:  2008-08-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.